USPTO serial 77874351
µGL
Reviewed by CopyMark Law Group
- Filing date
- Status date
- Registration date
- Dec 20, 2011
- Examiner
- TOOLEY, DAVID E
- Law office
- PUBLICATION AND ISSUE SECTION
What this means
Status 710 means the registration was cancelled because a required Section 8 declaration of continued use was not filed within the deadline (including any grace period). The federal registration is no longer active. Evaluate filing a new application if you still use the mark, or petition if cancellation was erroneous. Consult counsel on remaining common-law rights.
Need help with µGL?
If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.
Owner
Attorney of record
The USPTO lists this attorney as the applicant's representative for correspondence on this application.
Tomoko Nakajima
Tomoko Nakajima Cermak Nakajima LLP127 S. Peyton Street, Suite 210Alexandria, VA 22314UNITED STATESGoods and services
| Class | Description | Status | First use |
|---|---|---|---|
| 001 | Reagent for chemical analyses; Reagents for research purposes; Reagents for scientific or medical research use; Assays and reagents for use in genetic research; Diagnostic reagents for clinical or medical laboratory use; Diagnostic reagents for in vitro use in biochemistry, clinical chemistry and microbiology; Diagnostic reagents and preparations, except for medical or veterinary use; Genetic identity tests comprised of reagents; and Reagent kits comprising DNA chips for use in biotechnology fields; Reagents for detecting bacteria food poisoning | SECTION 8 - CANCELLED | — |
| 005 | Medical diagnostic reagents; Medical diagnostic reagents comprising DNA chips for clinical diagnosis; Reagents for medical use; Reagents and media for medical and veterinary diagnostic purposes; Reagents for clinical genetic diagnosis; Reagents for clinical biochemical diagnosis; Chemical reagents for medical purposes; Chemical reagents for clinical genetic diagnostics; Chemical reagents for clinical biochemical diagnostics; Chemical reagents in kit form for medical purposes; Chemical reagents in kit form for clinical genetic diagnostics; Chemical reagents in kit form for clinical biochemical diagnostics; Diagnostic reagents and contrast media for medical use; Diagnostic reagents for medicinal use; Test kits comprised of diagnostic reagents for clinical and medical use; Diagnostic preparations in kit form for medical purposes; Pharmaceutical preparations for use in genetic diseases; Test reagents for blood analysis for medical purpose | SECTION 8 - CANCELLED | — |
| 009 | Laboratory apparatus and instruments, namely, genome and gene testers, detectors, and analyzers; Computer software for operating genetic testing, detecting, and analyzing laboratory equipment; Computer software for scientific analysis of genetic sequences; Measuring and testing instruments, namely, genetic polymorphism analyzers, detectors, and testing device; Electrical equipment for the genetic modification of cells for research purposes | SECTION 8 - CANCELLED | — |
| 010 | Medical apparatus and instruments for medical diagnosis and genetic diagnostics; Medical apparatus and instruments for immunodiagnostics; Medical apparatus and instruments for biochemical diagnostics; Analyzers for medical purposes, namely, apparatus used to carry out automatic testing of biological samples; Medical apparatus and instruments for facilitating the analysis of biological and chemical matter in the field of genetic testing, namely blood, brain, urine, cerebrospinal fluid (csf) analysis and testing apparatus; Medical diagnosis devices, namely, analyzers and detectors of amplified viruses, extracted from human bodies; Apparatus for clinical diagnosis; Medical containers for medical reagent kits; Medical diagnostic devices, namely, kits consisting of containers, tubes, and genetic probes for extracting nucleic acid from biological samples; Medical diagnostic test kits consisting of testing containers and reagents for the purpose of detection and monitoring of inherited disease, genetic predispositions for medical conditions, drug responses, tumors or DNA conditions; Medical diagnostic apparatus and instruments, namely, devices with temperature controller and fluorescence detector for testing, analyzing, and evaluating biological material and samples for purpose of detection and monitoring of inherited disease, genetic predispositions for medical conditions, drug responses, tumors, and DNA conditions; Diagnostic apparatus for medical applications, namely, PCR machines, fluorescent detectors; Apparatus for diagnosing human genetic disease, infection disease, cardiac disease, tumors, and diabetes by the application of biochemical reaction | SECTION 8 - CANCELLED | — |
Related trademarks
CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.
- Other trademarks owned by Shimadzu Corporation
- Other trademarks owned by Shimadzu Corporation
- Other trademarks owned by Shimadzu Corporation
- Other trademarks in Class 001
- Other trademarks in Class 005
- Other trademarks in Class 009
- Other trademarks in Class 010
- Similar marks named µGL
- Recently changed USPTO trademarks
- Recently filed trademarks
- Browse all trademark records
Prosecution history
| Date | Code | Event | What it means |
|---|---|---|---|
| Jul 27, 2018 | C8.. | CANCELLED SEC. 8 (6-YR) | — |
| Dec 20, 2016 | REM1 | COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED | — |
| Dec 20, 2011 | R.PR | REGISTERED-PRINCIPAL REGISTER | Your trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive. |
| Oct 4, 2011 | NPUB | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED | — |
| Oct 4, 2011 | NPUB | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED | — |
| Oct 4, 2011 | PUBO | PUBLISHED FOR OPPOSITION | Your mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance. |
| Aug 27, 2011 | PREV | LAW OFFICE PUBLICATION REVIEW COMPLETED | — |
| Aug 24, 2011 | CNSA | APPROVED FOR PUB - PRINCIPAL REGISTER | — |
| Aug 24, 2011 | XAEC | EXAMINER'S AMENDMENT ENTERED | — |
| Aug 24, 2011 | GNEN | NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED | — |
| Aug 24, 2011 | GNEA | EXAMINERS AMENDMENT E-MAILED | — |
| Aug 24, 2011 | CNEA | EXAMINERS AMENDMENT -WRITTEN | — |
| Aug 23, 2011 | TEME | TEAS/EMAIL CORRESPONDENCE ENTERED | — |
| Aug 23, 2011 | CRFA | CORRESPONDENCE RECEIVED IN LAW OFFICE | — |
| Aug 23, 2011 | ERSI | TEAS RESPONSE TO SUSPENSION INQUIRY RECEIVED | — |
| Mar 10, 2011 | GNS2 | NOTIFICATION OF INQUIRY AS TO SUSPENSION E-MAILED | — |
| Mar 10, 2011 | GNSI | INQUIRY TO SUSPENSION E-MAILED | — |
| Mar 10, 2011 | CNSI | SUSPENSION INQUIRY WRITTEN | — |
| Feb 16, 2011 | RCCK | SUSPENSION CHECKED - TO ATTORNEY FOR ACTION | — |
| Feb 16, 2011 | ALIE | ASSIGNED TO LIE | — |
| Aug 13, 2010 | GNS3 | NOTIFICATION OF LETTER OF SUSPENSION E-MAILED | — |
| Aug 13, 2010 | GNSL | LETTER OF SUSPENSION E-MAILED | — |
| Aug 13, 2010 | CNSL | SUSPENSION LETTER WRITTEN | — |
| Jul 19, 2010 | TEME | TEAS/EMAIL CORRESPONDENCE ENTERED | — |
| Jul 16, 2010 | CRFA | CORRESPONDENCE RECEIVED IN LAW OFFICE | — |
| Jul 16, 2010 | TROA | TEAS RESPONSE TO OFFICE ACTION RECEIVED | This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action. |
| Apr 30, 2010 | TCCA | TEAS CHANGE OF CORRESPONDENCE RECEIVED | — |
| Feb 23, 2010 | GNRN | NOTIFICATION OF NON-FINAL ACTION E-MAILED | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Feb 23, 2010 | GNRT | NON-FINAL ACTION E-MAILED | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Feb 23, 2010 | CNRT | NON-FINAL ACTION WRITTEN | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Feb 23, 2010 | DOCK | ASSIGNED TO EXAMINER | — |
| Nov 23, 2009 | NWOS | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED | — |
| Nov 20, 2009 | NWAP | NEW APPLICATION ENTERED | — |